Early Alzheimer's Trials: What's the Buzz About?
Two big trials are underway to test a new drug called oral semaglutide. These trials, known as Evoke and Evoke+, are in their third phase and are looking at how safe and effective this drug is for people in the early stages of Alzheimer's disease. Why is this important? Well, Alzheimer's is a tough disease to treat. It's a type of dementia that affects memory, t...